oral tirzepatide studies sublingual study F.D.A. Approves New Obesity Drug

Despite challenges like high treatment costs, the market is anticipated to expand further, fueled by increasing clinical evidence, new regulatory approvals for additional indications, and the development of more affordable alternatives

So one thing people don't appreciate is that our weight is 40% to 70% genetic, and we don't yet have gene therapy, but we do have bariatric surgery, which is very effective, and then these GLP injectable medications

On average, tirzepatide has shown greater weight loss than semaglutide in head-to-head clinical research, but individual results can vary

Whether it can cause hair loss by some other mechanism is not clear

Reduced inflammation